The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma
Chloé B. Steen(Stanford University), Ash A. Alizadeh(California Institute for Regenerative Medicine), Aaron M. Newman(California Institute for Regenerative Medicine), June H. Myklebust(Oslo University Hospital), Mohammad Shahrokh Esfahani(Stanford Medicine), Andrew J. Gentles(Stanford Medicine), Barzin Y. Nabet(Gene Therapy Laboratory), Armon Azizi(Stanford University), Farnaz Khameneh(Stanford University), Chih Long Liu(Stanford University), Bogdan Luca(Bristol-Myers Squibb (Switzerland)), Ranjana H. Advani(Stanford Medicine), Brian J. Sworder(City Of Hope National Medical Center), Maximilian Diehn(Stanford University), David M. Kurtz(Stanford University), Yasodha Natkunam(Palo Alto University)
Cited by 317
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|9.9k
The Immune Landscape of Cancer
|Immunity|2018|6.2k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies
|Journal of Clinical Oncology|2012|1.1k
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
|Nature Medicine|2015|1.1k